3 reports

The drug candidate is in Phase II stage for peanut allergy in adults and pediatrics, grass pollen allergy and dermatitis globally.

  • Antifungal
  • Clinical Trial
  • Digestive System Disorder
  • Monoclonal Antibody
  • United States

The drug candidate binds to and inhibits the mRNA of Orai ##, inhibiting the calcium transport.

  • Antifungal
  • Clinical Trial
  • Digestive System Disorder
  • Therapy
  • United States

THE DRUG CANDIDATE IS IN PHASE II STAGE FOR PEANUT ALLERGY IN ADULTS AND PEDIATRICS, GRASS POLLEN ALLERGY AND DERMATITIS GLOBALLY.

  • Antifungal
  • Clinical Trial
  • Digestive System Disorder
  • United States
  • AstraZeneca PLC